Summary
- Profile Type
- Technology request
- POD Reference
- TRNL20240926006
- Term of Validity
- 26 September 2024 - 26 September 2025
- Company's Country
- Netherlands
- Type of partnership
- Research and development cooperation agreement
- Targeted Countries
- Denmark
- France
- Luxembourg
- Spain
- Belgium
- United Kingdom
- Germany
- Sweden
- Italy
- Finland
- Austria
- Norway
- Ireland
- Poland
- Japan
- Singapore
- South Korea
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- This Dutch SME operates in the fields of artificial intelligence (AI), wearables, and brain research. Their core expertise lies in developing solutions that can predict, manage and prevent neurological conditions, such as epilepsy, using non-invasive and invasive devices. They need partners that can help, advance their research and development in the following areas: Wearable Device Innovation, Neurology and Clinical Partners, Regulatory and Clinical, Data Collection and Analysis.
- Full Description
-
The Dutch SME is an innnovate company that operates in the fields of artificial intelligence (AI), wearables, and brain research. As a Pathfinder beneficiary, this company has a strong track record in collaborative, multi-disciplinary projects. With a focus on developing technologies that leverage brain data for real-world applications. The company has extensive experience working with global partners across various sectors, including universities, research institutions, small and medium enterprises (SMEs), large corporations, and healthcare organizations.
The company specializes in creating advanced wearable devices that monitor brain activity and apply AI to interpret neural signals in real time. Their core expertise lies in developing solutions that can predict, manage and prevent neurological conditions, such as epilepsy, using non-invasive and invasive devices.
Areas of Expertise:
• AI-Driven Brain Signal Analysis: Developing advanced algorithms for analyzing brain signals to predict and prevent neurological events.
• Wearable Devices: Specializing in the design of compact, user-friendly wearable devices for real-time brain monitoring.
• Seizure Prediction: Leading research in the field of epilepsy, focusing on AI models that can predict seizures with high accuracy.
• Neurotech Innovation: Working on solutions that integrate neuroscience and AI to create practical applications for both clinical and personal use.
They seek for collaboration opportunities with universities, small and medium-sized enterprises (SMEs), large companies, and hospitals that are engaged in brain research. Specifically, they aim to build partnerships that can help, advance their research and development efforts in the following areas:
• Wearable Device Innovation
• Neurology and Clinical Partners
• Data Collection and Analysis
• Regulatory and Clinical Trials Expertise
They also seek for partners to collaborate on international programs (e.g., Horizon Europe, Eureka) and regional programs (e.g., Inerreg) - Advantages and Innovations
-
The Dutch SME's innovative device offers comprehensive seizure coverage, predicting both convulsive and non-convulsive seizures in real time. Many existing devices focus solely on convulsive seizures, leaving patients vulnerable to non-convulsive episodes, which can be equally dangerous and potentially life-threatening. Given that many patients experience both types of seizures, the ability to predict all seizure forms is essential for ensuring full patient protection.
The device provides real-time seizure prediction with immediate alerts, allowing timely interventions and significantly enhancing patient safety. Unlike traditional technologies that primarily focus on detection or monitoring, this device accurately predicts seizures before they happen. A key advantage of the AI system developed by the Dutch SME is that it is not a "black box"—it operates transparently and complies with regulatory requirements, ensuring it meets the highest standards for safety and efficacy.
In addition, the novel AI is versatile and can be applied to the prediction of other brain anomalies, such as migraines, multiple sclerosis (MS), Parkinson's, and Alzheimer's disease, further extending the potential of this groundbreaking technology beyond seizure management. - Stage of Development
- Under development
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR description
-
Their device is ready for clinical validation and further improvements in compact-design development. The AI system is highly adaptable and can be implemented not only in other brain data sets but also in other non-invasive and invasive devices, expanding its use case across a wider range of applications in brain monitoring and neurological care.
The company is also exploring collaborations to combine their prediction technology with seizure prevention mechanisms, such as pharmaceutical interventions or neurostimulation techniques, to further improve clinical outcomes for patients. This approach aims to not only predict but also prevent seizures, offering a more comprehensive solution for managing neurological conditions.
Partner Sought
- Expected Role of a Partner
-
The company is actively seeking collaboration opportunities with universities, small and medium-sized enterprises (SMEs), large companies, and hospitals that are engaged in brain research. Partners to collaborate on international programs (e.g., Horizon Europe, Eureka) and regional programs (e.g., Inerreg) are also of interest.
Specifically, they aim to build partnerships that can help them advance their research and development efforts in the following areas:
1. Wearable Device Innovation: Collaboration with companies that are developing or researching next-generation wearable devices is key. They are particularly interested in working with hardware manufacturers who specialize in miniaturization, sensor integration, single-chip design and ergonomics.
2. Neurology and Clinical Partners: Hospitals, neurological institutes, and research centers with a focus on epilepsy, neurological disorders, or brain health are vital partners for them. These institutions can help them test and validate their technologies in clinical settings, ensuring that their products meet the highest standards of patient care.
3. Data Collection and Analysis: Collaborating with universities or companies that have access to large datasets of brainwave activity or neurological health data would support their AI training and validation efforts.
4. Regulatory and Clinical Trials Expertise: They seek partners who can support them in navigating regulatory pathways, particularly those experienced with clinical trials to bring AI-powered neurotechnologies to market. - Type and Size of Partner
- Other
- University
- R&D Institution
- SME <=10
- Big company
- SME 50 - 249
- SME 11-49
- Type of partnership
- Research and development cooperation agreement
Dissemination
- Technology keywords
- 06005003 - Health information management
- 06005002 - Sensors & Wireless products
- Market keywords
- 05004005 - Diagnostic equipment
- 05001007 - Other diagnostic
- Targeted countries
- Denmark
- France
- Luxembourg
- Spain
- Belgium
- United Kingdom
- Germany
- Sweden
- Italy
- Finland
- Austria
- Norway
- Ireland
- Poland
- Japan
- Singapore
- South Korea